English
全部
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
搜索
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
EMBO Press
10 天
PARP7 as a new target for activating anti-tumor immunity in cancer
PARP7 is a mono-ADP-ribosyl transferase (mono-ART) which has recently gained attention due to its emerging role as a negative ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Dow Jones plunges
Announces reciprocal tariffs
Corruption case dismissed
Joins list of TikTok suitors
Nashville shooting report
Average salary tops $5M
US bans staff in China
Teen dead, student arrested
US revokes visas
AR death row inmate dies
To run as an independent
Myanmar death toll rises
Switch 2 to launch in June
Closes China tariff loophole
Senate rebukes Trump
Chocolate bars recalled
Former Raiders OL dies
Entire LIHEAP staff laid off
Set for arthroscopic surgery
Enters NH Senate race
Daughters sue brother
Migrant boat capsizes
Multi-year deal with Meta
Exiting 'Inside Edition'
Deepest US lake to close
Misses deadline for decision
EU on US tariffs
Boeing CEO testifies
Hungary to pull out of ICC
反馈